These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33823556)

  • 1. Uptake of universal drug susceptibility testing among people with TB in a south Indian district: How are we faring?
    Ranganath R; Shewade HD; Bahadur AK; Naik V; Nagaraja SB; Kumar AMV; Peerapur BV; Babu S; Somshekhar N; Singarajipur A
    Trans R Soc Trop Med Hyg; 2022 Jan; 116(1):43-49. PubMed ID: 33823556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing?
    Shankar S U; Kumar AMV; Venkateshmurthy NS; Nair D; Kingsbury R; R P; Velu M; P S; Gupta J; Ahmed J; G P; Hiremath S; Jaiswal RK; Kokkad RJ; N S
    PLoS One; 2021; 16(1):e0244785. PubMed ID: 33406153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in rifampicin and isoniazid resistance in patients with presumptive TB.
    Palani N; Premkumar M; Vaishnavee V; Dinesh V; Thiruvengadam K; Lavanya J; Sridhar R; Frederick A; Sivaramakrishnan G; Mondal R; Padmapriyadarsini C; Shanmugam S
    Int J Tuberc Lung Dis; 2022 May; 26(5):446-453. PubMed ID: 35505474
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
    Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
    PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
    Raizada N; Sachdeva KS; Chauhan DS; Malhotra B; Reddy K; Dave PV; Mundade Y; Patel P; Ramachandran R; Das R; Solanki R; Wares DF; Sahu S; O'Brien R; Paramasivan CN; Dewan PK
    PLoS One; 2014; 9(2):e88626. PubMed ID: 24586360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
    Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of UDST: A step forward to end TB.
    Kumar Sharma A; Vijay S; Mathur RB; Meena H
    Indian J Tuberc; 2020 Apr; 67(2):213-215. PubMed ID: 32553314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on procedural delay in diagnosis and start of treatment in drug resistant tuberculosis under RNTCP.
    Sharma AK; Gupta N; Verma S; Chandran A; Dixit R
    Indian J Tuberc; 2019 Jul; 66(3):394-401. PubMed ID: 31439186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement between CBNAAT, liquid culture and line probe assay for detection of Mycobacterium tuberculosis and anti-tubercular drug resistance in extrapulmonary samples.
    Jain P; Singh U; Kumar V; Ratnam R; Jain A
    Indian J Med Microbiol; 2022; 40(3):365-369. PubMed ID: 35710480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
    Skenders GK; Holtz TH; Riekstina V; Leimane V
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain
    Timire C; Sandy C; Kumar AMV; Ngwenya M; Murwira B; Takarinda KC; Harries AD
    Int J Infect Dis; 2019 Apr; 81():236-243. PubMed ID: 30776546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of automated liquid culture and molecular line probe assay in smear-negative pulmonary tuberculosis.
    Kotwal A; Biswas D; Raghuvanshi S; Sindhwani G; Kakati B; Sharma S
    Trop Doct; 2017 Apr; 47(2):118-123. PubMed ID: 27784827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of line probe assay in detection of Mycobacterium tuberculosis in children with pulmonary tuberculosis.
    Bangarwa M; Dhingra D; Mittal M; Saigal K; Ghosh A
    Indian J Tuberc; 2023; 70 Suppl 1():S100-S103. PubMed ID: 38110251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
    Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
    PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Line probe assay for detection of
    Desikan P; Panwalkar N; Mirza SB; Chaturvedi A; Ansari K; Varathe R; Chourey M; Kumar P; Pandey M
    Indian J Med Res; 2017 Jan; 145(1):70-73. PubMed ID: 28574017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
    Kassa GM; Merid MW; Muluneh AG; Wolde HF
    PLoS One; 2021; 16(2):e0246938. PubMed ID: 33600409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.